Dive into the archives.


  • Hot off the AAN Press (belatedly): High Doses of Vitamin D Cut MS Relapses

    April 28, 2009 (Seattle) — High doses of vitamin D dramatically cut the relapse rate in people with multiple sclerosis, a study shows. Sixteen percent of 25 people with multiple sclerosis (MS) given an average of 14,000 international units (IU) of vitamin D a day for a year suffered relapses, says Jodie Burton, MD, a [...]

  • Cigarettes and MS: More Evidence of a Bad Combination

    Rebecca Hoover Unfortunately, cigarette smoking seems to be part of the multiple sclerosis (MS) picture for some patients.  Studies have shown that cigarette smoking increases the chances of getting MS and seems to make MS worse.  If you smoke, it is important to quit. The amount by which cigarette smoking increases multiple sclerosis is not [...]

  • 1 in 4 MS Patients Don’t Fill Scripts

    New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out-of-Pocket Costs Not Filling Prescriptions ST. PAUL, Minn., June 17, 2009 /PRNewswire via COMTEX/ — One in four multiple sclerosis (MS) patients are declining to fill their prescriptions likely due to high out-of-pocket costs, according to new research conducted by pharmacy benefits manager Prime [...]

  • More Power to You, NYU

    NYU Study May Find Better Treatments For MS Doctors at New York University are conducting a medical study that may determine the best treatments to slow the advancement of multiple sclerosis. NY1′s Health reporter Kafi Drexel filed the following report. David Rice Jr. had not even reached his 40th birthday when he found out he [...]

  • Biogen Says Eighth Patient Has Infection From Tysabri

    By Tom Randall June 12 (Bloomberg) — Biogen Idec said a patient taking its multiple sclerosis drug Tysabri was diagnosed with a life-threatening brain illness, the eighth case reported in the last year. The patient was confirmed to have progressive multifocal leukoencephalopathy, or PML, on June 10, according to a report on Cambridge, Massachusetts-based Biogen’s [...]

  • What do you get when you cross a German, a Mouse, and a White Blood Cell?

    Over 100,000 people suffer from multiple sclerosis in Germany alone. Despite intensive research, the factors that trigger the disease and influence its progress remain unclear. Scientists from the Max Planck Institute of Neurobiology in Martinsried and an international research team have succeeded in attaining three important new insights into the disease. It would appear that [...]

  • Diabetes drug may aid multiple sclerosis

    CHICAGO, May 27 (UPI) — U.S. medical researchers say they’ve found a drug used to treat diabetes shows protective effects in the brains of some multiple sclerosis patients. Researchers at the University of Illinois-Chicago College of Medicine say they conducted a small, double-blind clinical trial involving patients with relapsing remitting multiple sclerosis. The patients were [...]

  • Treating MS with Natural Remedies

    Hydrangea Root Shows Promise In Treating Autoimmune Disorders US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed promising results in treating autoimmune disorders such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, type 1 diabetes, eczema and psoriasis. The study [...]

June

This is the archive for June, 2009.

TAG / CLOUD

AAN, alemtuzumab, Avonex, Bayer, Betaseron, Biogen, BioMS Medical Corp, CCSVI, CIS, Cladribine, CLARITY, cognitive dysfunction, Copaxone, daclizumab, dirucotide, discovery, EAE, ECTRIMS, Elan, Fampridine-SR, FDA, FDA fast track status, fingolimod, FTY-720, Gilenia, interferons, laquinimod, Marijuana, Merck, Merck/Serono, Novartis, Oral MS Therapies, Phase III, PML, Rebif, remyelination, RRMS, side effects, smoking, SPMS, stem cells, Teriflunomide, Teva, therapy, Tysabri

Archives



Follow me on Twitter
Fave this on Technorati


Bookmark and Share


Wordpress Engine. Upstart Theme. Better Project.